Atlas Trials

Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo

Clinical trial NCT03025945 · COMPLETED

Trial details

NCT number
NCT03025945
Sponsor
Intuor Technologies, Inc.
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Cystoid Macular Edema
Start date
2013-10-01
Primary completion
2017-01-01
Enrollment
662

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.